🇺🇸 FDA
Patent

US 7341993

Cross-linked glycopeptide—cephalosporin antibiotics

granted A61KA61K31/545A61K38/00

Quick answer

US patent 7341993 (Cross-linked glycopeptide—cephalosporin antibiotics) held by Theravance, Inc. expires Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/545, A61K38/00, A61P, A61P31/00